LP
AVXL icon

LMR Partners’s Anavex Life Sciences AVXL Stock Holding History

LMR Partners’s Portfolio AVXL Stock Details AVXL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-35,200
Closed -$125K – 1461
2025
Q4 		$125K Buy
+35,200
New +$216K ﹤0.01% 1324
2025
Q2 		– Sell
-25,000
Closed -$215K – 1380
2025
Q1 		$215K Hold
25,000
– – ﹤0.01% 1047
2024
Q4 		$269K Buy
+25,000
New +$192K ﹤0.01% 923
2024
Q1 		– Sell
-25,000
Closed -$233K – 1156
2023
Q4 		$233K Hold
25,000
– – ﹤0.01% 724
2023
Q3 		$164K Buy
+25,000
New +$199K ﹤0.01% 648

Other funds holding AVXL

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return
SF
Summit Financial Parsippany, New Jersey $9.12B AUM 27.44% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

LMR Partners's AVXL Position: Q3 2018 in Review

LMR Partners sold out of Anavex Life Sciences (AVXL) in Q3 2018, closing a stake of 121,705 shares — an estimated $319K sold.

LMR Partners first reported a position in AVXL in Q2 2018 and held it in 1 quarter. The position peaked at $319K in Q2 2018. 48 funds tracked by Wall St. Rank hold AVXL as of Q3 2018.

  • LMR Partners reported no remaining Anavex Life Sciences position as of Q3 2018 after selling out during the quarter.
  • LMR Partners sold 121,705 Anavex Life Sciences shares in Q3 2018, an estimated $319K.
  • LMR Partners first reported a position in Anavex Life Sciences in Q2 2018 and held it in 1 quarter.
  • LMR Partners's Anavex Life Sciences position peaked at $319K in Q2 2018.
  • 48 funds tracked by Wall St. Rank held Anavex Life Sciences as of Q3 2018.

Based on LMR Partners's 13F filing for Q3 2018, filed 14 Nov 2018.